AJDRAJNR - American Journal of Neuroradiology

Published ahead of print on March 27, 2008
doi: 10.3174/ajnr.A1075

This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajnr.A1075v1
29/7/e57    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galanaud, D.
Right arrow Articles by Ranjeva, J.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galanaud, D.
Right arrow Articles by Ranjeva, J.P.

Letter

Differences of Apparent Diffusion Coefficient Values in Patients with Creutzfeldt-Jakob Disease According to the Codon 129 Genotype

D. Galanauda and D. Dormonta

a Department of Neuroradiology
CNRS UPR 640 LENA

S. Haïkb

b Department of Pathology

J. Chirasc

c Department of Neuroradiology
Cellule de référence des maladies à prions
INSERM, Avenir Team-Human Prion Diseases

J.P. Brandeld

d Cellule de référence des maladies à prions
INSERM, Avenir Team-Human Prion Diseases
Pitié Salpêtrière Hospital
Paris, France

J.P. Ranjevae

e CRMBM-CEMEREM
Faculté de Médecine La Timone
Marseille, France

We read with great interest the article by Tschampa et al1 analyzing the patterns of lesions, mostly on cortical areas, in patients with Creutzfeldt-Jakob disease (CJD). Although this study confirmed the high sensitivity of diffusion imaging, the authors did not find any differences between the 3 subtypes (MM, MV, VV) of the disease associated with the methionine/valine polymorphism at codon 129 of the prion protein gene. In this retrospective study, only diffusion-weighted images (DWIs) were reviewed, and apparent diffusion coefficient (ADC) values were not calculated. We performed a study that showed that ADC values are of interest in CJD diagnosis, as was previously suggested.2

We prospectively studied 20 patients with CJD (6 pathology-proved and 14 probable) and 10 age-matched controls. The codon 129 genotype was available for 15 subjects, who included 1 VV, 8 MM, and 6 MV subtypes. The MR imaging protocol included both fluid-attenuated inversion recovery (FLAIR) and diffusion sequences (DWI, b = 0, 500, 750, and 1000 s/mm2). In these patients, we found the same high frequency of lesions (15/15 on FLAIR and DWI), both on the cortex (13/15 on FLAIR, 15/15 on DWI) and on the basal ganglia (10/15 on FLAIR, 12/15 on DWI). The frequency of involvement of the striatum was similar on DWI in MM (6/8) and MV (5/6) genotypes. In addition, ADC values measured on the deep brain structures were significantly lower in patients with the MV and VV genotypes as compared with MM patients (P < .03 in the caudate, lenticular, and pulvinar nuclei; {chi}2 test). The difference was striking in the caudate nucleus, where ADC values were significantly different between controls and MM and MV/VV patients, with a clear-cut separation between MM and MV/VV patients (Fig 1). ADC values were not significantly different between controls and MM patients in the lenticular nucleus, despite the presence of signal-intensity changes on DWIs in 75% of these patients. These findings support a combination of different pathologic processes to explain the hypersignals observed on DWI, inducing increased and/or decreased diffusibility and emphasizing the added value of ADC measures to distinguish in vivo between molecular subtypes of CJD.


Figure 1
View larger version (16K):
[in this window]
[in a new window]

 
Fig 1. ADC values measured on the head of the caudate nuclei in patients with CJD with the MM (n = 8), MV (n = 6), and VV (n = 1, same column as MV, triangle) phenotypes and controls (n = 10). There is a statistical difference between all 3 groups (P < 10–4) and a clear-cut separation between patients with the MM and MV/VV phenotypes.

References

  1. Tschampa HJ, Kallenberg K, Kretzschmar HA, et al. Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 2007;28:1114–18[Abstract/Free Full Text]

  2. Tschampa HJ, Murtz P, Flacke S, et al Thalamic involvement in sporadic Creutzfeldt-Jakob disease: a diffusion-weighted MR imaging study. AJNR Am J Neuroradiol 2003;24:908–15[Abstract/Free Full Text]





This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajnr.A1075v1
29/7/e57    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galanaud, D.
Right arrow Articles by Ranjeva, J.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galanaud, D.
Right arrow Articles by Ranjeva, J.P.